Illumina Inc. Stock Underperforms Tuesday When Compared To Competitors
I'm PortAI, I can summarize articles.
Illumina Inc.'s stock fell 1.02% to $136.19 on Tuesday, underperforming compared to competitors like Labcorp Holdings, Charles River Laboratories, and Quest Diagnostics. This decline ended a three-day winning streak, with the stock closing 11.02% below its 52-week high. The trading volume was significantly below the 50-day average. The S&P 500 and Dow Jones both saw gains on the same day.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Dow Jones The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments